Lobbying client · LD-2 disclosures
Pervasis Therapeutics
Massachusetts
1 filing from 1 registrant · 2009–2010 · latest filed Sept 22, 2010
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who did the lobbying
Every lobbyist named on this client's filings.
- Stephen Cooper K&L Gates, LLP1 filingthrough 2009
- Jaya Naomi Ghildiyal K&L Gates, LLP1 filingthrough 2009
- Amy Carnevale K&L Gates, LLPCovered position: of Natl Drug Council Policy, EOP; Perm Volunteer, Office ofPolitical Affairs/Office of Presidential Pers, White House1 filingthrough 2009
Covered positions · 1 of 3 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: pervasis-therapeutics.